查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1667933

颈椎病诊断和治疗市场 - 全球行业规模、份额、趋势、机会和预测，按诊断、按产品类型、按配销通路、按地区和竞争进行细分，2020-2030 年

Cervical Spondylosis Diagnosis And Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Diagnosis, By Product Type, By Distribution Channel, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024 年全球颈椎病诊断和治疗市场价值为 64.3 亿美元，预计到 2030 年将达到 95.2 亿美元，预测期内复合年增长率为 6.72%。全球颈椎病诊断和治疗市场的主要推动因素是颈椎病患病率的上升，尤其是在老年人口和久坐生活方式的人中。人们对该疾病的认识不断提高，加上 MRI 和 CT 扫描等诊断技术的进步，改善了早期发现和治疗结果。对物理治疗、药物和微创手术等非侵入性治疗方案的需求不断增长，促进了市场扩张。先进手术技术的发展和术后护理的改善正在提高治疗效果和患者的康復。生物製剂和再生医学的创新以及对个人化医疗的日益关注，有望为颈椎病提供更有针对性和更有效的治疗选择，从而推动市场的成长。

市场概况
预测期 2026-2030
2024 年市场规模 64.3 亿美元
2030 年市场规模 95.2 亿美元
2025-2030 年复合年增长率 6.72％
成长最快的领域 磁振造影
最大的市场 北美洲

主要市场驱动因素

颈椎病患病率不断上升

主要市场挑战

治疗费用高昂

主要市场趋势

再生医学日益受到关注

目录

第 1 章：产品概述

第 2 章：研究方法

第 3 章：执行摘要

第 4 章：顾客之声

第五章：全球颈椎病变诊断与治疗市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 根据诊断（影像学检查、颈部 X 光、MRI、CT 脊髓造影、神经功能测试、肌电图和神经传导研究）
    • 依产品类型（药品、医疗器材和手术器材）
    • 按配销通路（医院药房、零售药房和网路药房）
    • 按地区
    • 按公司分类（2024）
  • 市场地图

第六章：北美颈椎病诊断与治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 北美：国家分析
    • 加拿大
    • 墨西哥

第七章：欧洲颈椎病诊断与治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 欧洲：国家分析
    • 英国
    • 义大利
    • 法国
    • 西班牙

第 8 章：亚太颈椎病诊断与治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 亚太地区：国家分析
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：南美洲颈椎病诊断与治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • 南美洲：国家分析
    • 阿根廷
    • 哥伦比亚

第 10 章：中东和非洲颈椎病诊断与治疗市场展望

  • 市场规模和预测
  • 市场占有率和预测
  • MEA：国家分析
    • 沙乌地阿拉伯
    • 阿联酋

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 合併与收购（如有）
  • 产品发布（如果有）
  • 最新动态

第 13 章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的力量
  • 顾客的力量
  • 替代产品的威胁

第 14 章：竞争格局

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

第 15 章：策略建议

第16章 调査会社について・免责事项

简介目录
Product Code: 27676

Global Cervical Spondylosis Diagnosis And Treatment Market was valued at USD 6.43 Billion in 2024 and is expected to reach USD 9.52 Billion by 2030 with a CAGR of 6.72% during the forecast period. The global cervical spondylosis diagnosis and treatment market is primarily driven by the rising prevalence of cervical spondylosis, particularly among the aging population and individuals with sedentary lifestyles. Increased awareness of the condition, coupled with advances in diagnostic technologies such as MRI and CT scans, has improved early detection and treatment outcomes. The growing demand for non-invasive treatment options, including physical therapy, medications, and minimally invasive surgeries, is contributing to market expansion. The development of advanced surgical techniques and improved post-operative care are enhancing treatment effectiveness and patient recovery. Innovations in biologics and regenerative medicine, along with an increasing focus on personalized healthcare, are expected to fuel growth in the market by providing more targeted and effective treatment options for cervical spondylosis.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 6.43 Billion
Market Size 2030USD 9.52 Billion
CAGR 2025-20306.72%
Fastest Growing SegmentMRI
Largest MarketNorth America

Key Market Drivers

Increasing Prevalence of Cervical Spondylosis

The rising prevalence of cervical spondylosis is one of the primary factors driving the global market. Cervical spondylosis is more common in individuals over the age of 40, with its incidence increasing with age due to the natural wear and tear of the cervical spine. As global life expectancy rises, the elderly population is expected to grow significantly, contributing to a higher number of cervical spondylosis cases. Most individuals with spondylotic changes in the cervical spine, as seen on radiographic imaging, remain asymptomatic. However, approximately 25% of those under the age of 40, 50% of individuals over 40, and 85% of people over 60 show signs of degenerative changes. The most commonly affected vertebral levels are C6-C7, followed by C5-C6. Symptomatic cervical spondylosis typically manifests as neck pain. In the general population, the point prevalence of neck pain ranges from 0.4% to 41.5%, the 1-year incidence ranges from 4.8% to 79.5%, and lifetime prevalence can be as high as 86.8%.

Key Market Challenges

High Treatment Costs

One of the primary challenges in the cervical spondylosis diagnosis and treatment market is the high cost of treatment. Advanced diagnostic techniques such as MRI and CT scans, as well as sophisticated surgical interventions, can be prohibitively expensive, especially in low and middle-income countries. Minimally invasive surgeries, stem cell therapies, and other innovative treatment options, while highly effective, are often costly and may not be affordable for many patients. The high treatment costs place a significant burden on healthcare systems, patients, and insurance providers. Even in regions with robust healthcare infrastructure, the financial strain on patients can deter them from seeking timely treatment, which could lead to worsened health outcomes. This economic barrier to access is a challenge that hinders broader adoption of advanced treatments, especially in developing regions.

Key Market Trends

Rising Focus on Regenerative Medicine

Regenerative medicine is an emerging field that is driving significant growth in the cervical spondylosis market. This field includes the use of biologics such as stem cell therapy, platelet-rich plasma (PRP) injections, and growth factor therapies, all of which are being explored as potential treatments for cervical spondylosis. Stem cell therapy, in particular, holds great promise for patients with severe disc degeneration by promoting the regeneration of damaged tissues and encouraging the healing of spinal discs. PRP therapy involves the use of a patient's own blood platelets to promote healing and reduce inflammation in the affected cervical area. Regenerative medicine offers a more natural and minimally invasive alternative to traditional surgery, providing new hope for patients who are not candidates for more invasive procedures. As research and clinical trials continue to explore the efficacy of these treatments, regenerative medicine is expected to play an increasingly important role in managing cervical spondylosis, driving the demand for related therapies and treatments in the global market.

Key Market Players

  • Novartis AG
  • Merck & Co. Inc.
  • Bayer AG
  • Abbott Laboratories Inc.
  • Ortho Bracing
  • Medtronic Plc
  • Stryker Corporation
  • B. Braun SE
  • DJO, LLC
  • Aspen Medical Products, LLC

Report Scope:

In this report, the Global Cervical Spondylosis Diagnosis And Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Cervical Spondylosis Diagnosis And Treatment Market, By Diagnosis:

  • Imaging Tests
  • Neck X-ray
  • MRI
  • CT Myelography
  • Nerve Function Tests
  • Electromyography
  • Nerve Conduction Study

Cervical Spondylosis Diagnosis And Treatment Market, By Product Type:

  • Medications
  • Medical Devices
  • Surgical Instruments

Cervical Spondylosis Diagnosis And Treatment Market, By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Cervical Spondylosis Diagnosis And Treatment Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Cervical Spondylosis Diagnosis And Treatment Market.

Available Customizations:

Global Cervical Spondylosis Diagnosis And Treatment market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Diagnosis (Imaging Tests, Neck X-ray, MRI, CT Myelography, Nerve Function Tests, Electromyography, and Nerve Conduction Study)
    • 5.2.2. By Product Type (Medications, Medical Devices, and Surgical Instruments)
    • 5.2.3. By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Diagnosis
    • 6.2.2. By Product Type
    • 6.2.3. By Distribution Channel
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Diagnosis
        • 6.3.1.2.2. By Product Type
        • 6.3.1.2.3. By Distribution Channel
    • 6.3.2. Canada Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Diagnosis
        • 6.3.2.2.2. By Product Type
        • 6.3.2.2.3. By Distribution Channel
    • 6.3.3. Mexico Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Diagnosis
        • 6.3.3.2.2. By Product Type
        • 6.3.3.2.3. By Distribution Channel

7. Europe Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Diagnosis
    • 7.2.2. By Product Type
    • 7.2.3. By Distribution Channel
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Diagnosis
        • 7.3.1.2.2. By Product Type
        • 7.3.1.2.3. By Distribution Channel
    • 7.3.2. United Kingdom Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Diagnosis
        • 7.3.2.2.2. By Product Type
        • 7.3.2.2.3. By Distribution Channel
    • 7.3.3. Italy Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Diagnosis
        • 7.3.3.2.2. By Product Type
        • 7.3.3.2.3. By Distribution Channel
    • 7.3.4. France Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Diagnosis
        • 7.3.4.2.2. By Product Type
        • 7.3.4.2.3. By Distribution Channel
    • 7.3.5. Spain Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Diagnosis
        • 7.3.5.2.2. By Product Type
        • 7.3.5.2.3. By Distribution Channel

8. Asia-Pacific Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Diagnosis
    • 8.2.2. By Product Type
    • 8.2.3. By Distribution Channel
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Diagnosis
        • 8.3.1.2.2. By Product Type
        • 8.3.1.2.3. By Distribution Channel
    • 8.3.2. India Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Diagnosis
        • 8.3.2.2.2. By Product Type
        • 8.3.2.2.3. By Distribution Channel
    • 8.3.3. Japan Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Diagnosis
        • 8.3.3.2.2. By Product Type
        • 8.3.3.2.3. By Distribution Channel
    • 8.3.4. South Korea Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Diagnosis
        • 8.3.4.2.2. By Product Type
        • 8.3.4.2.3. By Distribution Channel
    • 8.3.5. Australia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Diagnosis
        • 8.3.5.2.2. By Product Type
        • 8.3.5.2.3. By Distribution Channel

9. South America Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Diagnosis
    • 9.2.2. By Product Type
    • 9.2.3. By Distribution Channel
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Diagnosis
        • 9.3.1.2.2. By Product Type
        • 9.3.1.2.3. By Distribution Channel
    • 9.3.2. Argentina Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Diagnosis
        • 9.3.2.2.2. By Product Type
        • 9.3.2.2.3. By Distribution Channel
    • 9.3.3. Colombia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Diagnosis
        • 9.3.3.2.2. By Product Type
        • 9.3.3.2.3. By Distribution Channel

10. Middle East and Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Diagnosis
    • 10.2.2. By Product Type
    • 10.2.3. By Distribution Channel
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Diagnosis
        • 10.3.1.2.2. By Product Type
        • 10.3.1.2.3. By Distribution Channel
    • 10.3.2. Saudi Arabia Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Diagnosis
        • 10.3.2.2.2. By Product Type
        • 10.3.2.2.3. By Distribution Channel
    • 10.3.3. UAE Cervical Spondylosis Diagnosis And Treatment Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Diagnosis
        • 10.3.3.2.2. By Product Type
        • 10.3.3.2.3. By Distribution Channel

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Novartis AG
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Merck & Co. Inc.
  • 14.3. Bayer AG
  • 14.4. Abbott Laboratories Inc.
  • 14.5. Ortho Bracing
  • 14.6. Medtronic Plc
  • 14.7. Stryker Corporation
  • 14.8. B. Braun SE
  • 14.9. DJO, LLC
  • 14.10. Aspen Medical Products, LLC

15. Strategic Recommendations

16. About Us & Disclaimer